202 related articles for article (PubMed ID: 21491498)
1. Central nervous system dysfunction in a mouse model of FA2H deficiency.
Potter KA; Kern MJ; Fullbright G; Bielawski J; Scherer SS; Yum SW; Li JJ; Cheng H; Han X; Venkata JK; Khan PA; Rohrer B; Hama H
Glia; 2011 Jul; 59(7):1009-21. PubMed ID: 21491498
[TBL] [Abstract][Full Text] [Related]
2. Absence of 2-hydroxylated sphingolipids is compatible with normal neural development but causes late-onset axon and myelin sheath degeneration.
Zöller I; Meixner M; Hartmann D; Büssow H; Meyer R; Gieselmann V; Eckhardt M
J Neurosci; 2008 Sep; 28(39):9741-54. PubMed ID: 18815260
[TBL] [Abstract][Full Text] [Related]
3. Increasing sulfatide synthesis in myelin-forming cells of arylsulfatase A-deficient mice causes demyelination and neurological symptoms reminiscent of human metachromatic leukodystrophy.
Ramakrishnan H; Hedayati KK; Lüllmann-Rauch R; Wessig C; Fewou SN; Maier H; Goebel HH; Gieselmann V; Eckhardt M
J Neurosci; 2007 Aug; 27(35):9482-90. PubMed ID: 17728461
[TBL] [Abstract][Full Text] [Related]
4. Myelination in the absence of UDP-galactose:ceramide galactosyl-transferase and fatty acid 2 -hydroxylase.
Meixner M; Jungnickel J; Grothe C; Gieselmann V; Eckhardt M
BMC Neurosci; 2011 Mar; 12():22. PubMed ID: 21366909
[TBL] [Abstract][Full Text] [Related]
5. Age-Dependent Increase in Schmidt-Lanterman Incisures and a Cadm4-Associated Membrane Skeletal Complex in Fatty Acid 2-hydroxylase Deficient Mice: a Mouse Model of Spastic Paraplegia SPG35.
Jordans S; Hardt R; Becker I; Winter D; Wang-Eckhardt L; Eckhardt M
Mol Neurobiol; 2022 Jul; 59(7):3969-3979. PubMed ID: 35445918
[TBL] [Abstract][Full Text] [Related]
6. FAHN/SPG35: a narrow phenotypic spectrum across disease classifications.
Rattay TW; Lindig T; Baets J; Smets K; Deconinck T; Söhn AS; Hörtnagel K; Eckstein KN; Wiethoff S; Reichbauer J; Döbler-Neumann M; Krägeloh-Mann I; Auer-Grumbach M; Plecko B; Münchau A; Wilken B; Janauschek M; Giese AK; De Bleecker JL; Ortibus E; Debyser M; Lopez de Munain A; Pujol A; Bassi MT; D'Angelo MG; De Jonghe P; Züchner S; Bauer P; Schöls L; Schüle R
Brain; 2019 Jun; 142(6):1561-1572. PubMed ID: 31135052
[TBL] [Abstract][Full Text] [Related]
7. FA2H is responsible for the formation of 2-hydroxy galactolipids in peripheral nervous system myelin.
Maldonado EN; Alderson NL; Monje PV; Wood PM; Hama H
J Lipid Res; 2008 Jan; 49(1):153-61. PubMed ID: 17901466
[TBL] [Abstract][Full Text] [Related]
8. Decreased turnover of the CNS myelin protein Opalin in a mouse model of hereditary spastic paraplegia 35.
Hardt R; Jordans S; Winter D; Gieselmann V; Wang-Eckhardt L; Eckhardt M
Hum Mol Genet; 2021 Jan; 29(22):3616-3630. PubMed ID: 33215680
[TBL] [Abstract][Full Text] [Related]
9. Novel biallelic FA2H mutations in a Japanese boy with fatty acid hydroxylase-associated neurodegeneration.
Kawaguchi M; Sassa T; Kidokoro H; Nakata T; Kato K; Muramatsu H; Okuno Y; Yamamoto H; Kaname T; Kihara A; Natsume J
Brain Dev; 2020 Feb; 42(2):217-221. PubMed ID: 31837835
[TBL] [Abstract][Full Text] [Related]
10. FA2H-dependent fatty acid 2-hydroxylation in postnatal mouse brain.
Alderson NL; Maldonado EN; Kern MJ; Bhat NR; Hama H
J Lipid Res; 2006 Dec; 47(12):2772-80. PubMed ID: 16998236
[TBL] [Abstract][Full Text] [Related]
11. Adult CNP::EGFP transgenic mouse shows pronounced hypomyelination and an increased vulnerability to cuprizone-induced demyelination.
Millet V; Marder M; Pasquini LA
Exp Neurol; 2012 Jan; 233(1):490-504. PubMed ID: 22155618
[TBL] [Abstract][Full Text] [Related]
12. Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS and PNS: neuropathology and behavioral deficits in single- and double-null mice.
Pan B; Fromholt SE; Hess EJ; Crawford TO; Griffin JW; Sheikh KA; Schnaar RL
Exp Neurol; 2005 Sep; 195(1):208-17. PubMed ID: 15953602
[TBL] [Abstract][Full Text] [Related]
13. Acetyl-CoA production from pyruvate is not necessary for preservation of myelin.
Della-Flora Nunes G; Mueller L; Silvestri N; Patel MS; Wrabetz L; Feltri ML; Poitelon Y
Glia; 2017 Oct; 65(10):1626-1639. PubMed ID: 28657129
[TBL] [Abstract][Full Text] [Related]
14. The deletion of dicer in mature myelinating glial cells causes progressive axonal degeneration but not overt demyelination in adult mice.
Li T; Wang J; Wang H; Yang Y; Wang S; Huang N; Wang F; Gao X; Niu J; Li Z; Mei F; Xiao L
Glia; 2018 Sep; 66(9):1960-1971. PubMed ID: 29726608
[TBL] [Abstract][Full Text] [Related]
15. Proteolipid protein modulates preservation of peripheral axons and premature death when myelin protein zero is lacking.
Patzig J; Kusch K; Fledrich R; Eichel MA; Lüders KA; Möbius W; Sereda MW; Nave KA; Martini R; Werner HB
Glia; 2016 Jan; 64(1):155-74. PubMed ID: 26393339
[TBL] [Abstract][Full Text] [Related]
16. Carboxypeptidase E conditional knockout mice exhibit learning and memory deficits and neurodegeneration.
Fan FC; Du Y; Zheng WH; Loh YP; Cheng Y
Transl Psychiatry; 2023 Apr; 13(1):135. PubMed ID: 37100779
[TBL] [Abstract][Full Text] [Related]
17. Neuroinflammation in white matter tracts of Cnp1 mutant mice amplified by a minor brain injury.
Wieser GL; Gerwig UC; Adamcio B; Barrette B; Nave KA; Ehrenreich H; Goebbels S
Glia; 2013 Jun; 61(6):869-80. PubMed ID: 23483656
[TBL] [Abstract][Full Text] [Related]
18. Absence of oligodendroglial glucosylceramide synthesis does not result in CNS myelin abnormalities or alter the dysmyelinating phenotype of CGT-deficient mice.
Saadat L; Dupree JL; Kilkus J; Han X; Traka M; Proia RL; Dawson G; Popko B
Glia; 2010 Mar; 58(4):391-8. PubMed ID: 19705459
[TBL] [Abstract][Full Text] [Related]
19. Reversal of non-hydroxy:alpha-hydroxy galactosylceramide ratio and unstable myelin in transgenic mice overexpressing UDP-galactose:ceramide galactosyltransferase.
Fewou SN; Büssow H; Schaeren-Wiemers N; Vanier MT; Macklin WB; Gieselmann V; Eckhardt M
J Neurochem; 2005 Jul; 94(2):469-81. PubMed ID: 15998297
[TBL] [Abstract][Full Text] [Related]
20. Oligodendrocyte-specific ceramide galactosyltransferase (CGT) expression phenotypically rescues CGT-deficient mice and demonstrates that CGT activity does not limit brain galactosylceramide level.
Zöller I; Büssow H; Gieselmann V; Eckhardt M
Glia; 2005 Nov; 52(3):190-8. PubMed ID: 15968630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
